BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23731241)

  • 21. A multi-analyte assay for the non-invasive detection of bladder cancer.
    Goodison S; Chang M; Dai Y; Urquidi V; Rosser CJ
    PLoS One; 2012; 7(10):e47469. PubMed ID: 23094052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.
    Jiménez B; Mirnezami R; Kinross J; Cloarec O; Keun HC; Holmes E; Goldin RD; Ziprin P; Darzi A; Nicholson JK
    J Proteome Res; 2013 Feb; 12(2):959-68. PubMed ID: 23240862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New findings on urinary prostate cancer metabolome through combined GC-MS and
    Lima AR; Pinto J; Barros-Silva D; Jerónimo C; Henrique R; Bastos ML; Carvalho M; Guedes Pinho P
    Metabolomics; 2020 Jun; 16(6):70. PubMed ID: 32495062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low- and high-grade bladder cancer determination via human serum-based metabolomics approach.
    Bansal N; Gupta A; Mitash N; Shakya PS; Mandhani A; Mahdi AA; Sankhwar SN; Mandal SK
    J Proteome Res; 2013 Dec; 12(12):5839-50. PubMed ID: 24219689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry.
    Issaq HJ; Nativ O; Waybright T; Luke B; Veenstra TD; Issaq EJ; Kravstov A; Mullerad M
    J Urol; 2008 Jun; 179(6):2422-6. PubMed ID: 18433783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary Volatiles and Chemical Characterisation for the Non-Invasive Detection of Prostate and Bladder Cancers.
    Tyagi H; Daulton E; Bannaga AS; Arasaradnam RP; Covington JA
    Biosensors (Basel); 2021 Nov; 11(11):. PubMed ID: 34821653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
    Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
    J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods.
    Zhang J; Bowers J; Liu L; Wei S; Gowda GA; Hammoud Z; Raftery D
    PLoS One; 2012; 7(1):e30181. PubMed ID: 22291914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unmasking the Metabolite Signature of Bladder Cancer: A Systematic Review.
    Pereira F; Domingues MR; Vitorino R; Guerra IMS; Santos LL; Ferreira JA; Ferreira R
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
    J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
    Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
    Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human Melanoma-Cell Metabolic Profiling: Identification of Novel Biomarkers Indicating Metastasis.
    Kosmopoulou M; Giannopoulou AF; Iliou A; Benaki D; Panagiotakis A; Velentzas AD; Konstantakou EG; Papassideri IS; Mikros E; Stravopodis DJ; Gikas E
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression.
    Putluri N; Shojaie A; Vasu VT; Vareed SK; Nalluri S; Putluri V; Thangjam GS; Panzitt K; Tallman CT; Butler C; Sana TR; Fischer SM; Sica G; Brat DJ; Shi H; Palapattu GS; Lotan Y; Weizer AZ; Terris MK; Shariat SF; Michailidis G; Sreekumar A
    Cancer Res; 2011 Dec; 71(24):7376-86. PubMed ID: 21990318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective evaluation of diffusion-weighted MRI of the bladder as a biomarker for prediction of bladder cancer aggressiveness.
    Sevcenco S; Ponhold L; Heinz-Peer G; Fajkovic H; Haitel A; Susani M; Shariat SF; Szarvas T; Baltzer PA
    Urol Oncol; 2014 Nov; 32(8):1166-71. PubMed ID: 24962659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic Evaluation of Urine from Patients Diagnosed with High Grade (HG) Bladder Cancer by SPME-LC-MS Method.
    Łuczykowski K; Warmuzińska N; Operacz S; Stryjak I; Bogusiewicz J; Jacyna J; Wawrzyniak R; Struck-Lewicka W; Markuszewski MJ; Bojko B
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33920347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic profiling of ob/ob mouse fatty liver using HR-MAS
    Gogiashvili M; Edlund K; Gianmoena K; Marchan R; Brik A; Andersson JT; Lambert J; Madjar K; Hellwig B; Rahnenführer J; Hengstler JG; Hergenröder R; Cadenas C
    Anal Bioanal Chem; 2017 Feb; 409(6):1591-1606. PubMed ID: 27896396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NMR-based plasma metabolomic discrimination for male fertility assessment of rats treated with Eurycoma longifolia extracts.
    Ebrahimi F; Ibrahim B; Teh CH; Murugaiyah V; Chan KL
    Syst Biol Reprod Med; 2017 Jun; 63(3):179-191. PubMed ID: 28306342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and validation of methylated PENK gene for early detection of bladder cancer using urine DNA.
    Oh TJ; Lim E; Bang BR; Lee JJ; Na YG; Shin JH; Lim JS; Song KH; An S
    BMC Cancer; 2022 Nov; 22(1):1195. PubMed ID: 36403035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary metabolomic signature of esophageal cancer and Barrett's esophagus.
    Davis VW; Schiller DE; Eurich D; Sawyer MB
    World J Surg Oncol; 2012 Dec; 10():271. PubMed ID: 23241138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discrimination of healthy and neoplastic human colon tissues by ex vivo HR-MAS NMR spectroscopy and chemometric analyses.
    Righi V; Durante C; Cocchi M; Calabrese C; Di Febo G; Lecce F; Pisi A; Tugnoli V; Mucci A; Schenetti L
    J Proteome Res; 2009 Apr; 8(4):1859-69. PubMed ID: 19714812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.